University of Washington: HIV Infections trials

The registry lists 50 HIV Infections studies with University of Washington as lead sponsor. 4 are open to participants now and 18 have results posted.

Phase 2 4Phase 3 6Phase 4 4No phase 37(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender WomenNot yet recruitingNCT07361926Not applicable
• HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIVRecruitingNCT06126913Not applicable
• One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care ProjectRecruitingNCT05905640Not applicable
• mWACh-PrEP: A SMS-based Support Intervention to Enhance PrEP Adherence During Pregnancy and BreastfeedingRecruitingNCT04472884Not applicable
• Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, WashingtonCompletedNCT06187064Not applicableResults posted
• Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in KenyaCompletedNCT05482360Not applicableResults posted
• The Women TAF-FTC Benchmark StudyCompletedNCT05140954Phase 2/3Results posted
• The Women TDF-FTC Benchmark StudyCompletedNCT05057858Phase 2Results posted
• Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid TestsCompletedNCT04880200Not applicableResults posted
• PrEPARE: PrEP in Pregnancy, Accelerating Reach and EfficiencyCompletedNCT04712994Not applicableResults posted
• The PrEP (Pre-exposure Prophylaxis) SMART StudyCompletedNCT04038060Not applicableResults posted
• Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in KenyaCompletedNCT03875950Not applicableResults posted
• Interventions to Improve the HIV PrEP Cascade Among Methamphetamine UsersCompletedNCT03584282Not applicableResults posted
• PrEP Implementation for Mothers in Antenatal CareCompletedNCT03070600Phase 4Results posted
• Patient Actor Training to Improve HIV Services for Adolescents in KenyaCompletedNCT02928900Not applicableResults posted
• Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ARTCompletedNCT02400671Not applicableResults posted
• Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)CompletedNCT02063880Not applicableResults posted
• Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)CompletedNCT01161446Not applicableResults posted
• Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant CouplesCompletedNCT00557245Phase 3Results posted
• Optimizing Pediatric HIV-1 Treatment, Nairobi, KenyaTerminatedNCT00428116Not applicableResults posted
• Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaTerminatedNCT00427297Phase 3Results posted
• ARVs to Prevent Breastmilk HIV:Viral and Immune ResponsesCompletedNCT00167674Phase 2Results posted
• CASI-Plus mHealth for Ukraine's APS Program (Aim 1)CompletedNCT06971120
• CASI-Plus mHealth for Ukraine's APS Program (Aim 2)CompletedNCT05826977Not applicable
• A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African WomenCompletedNCT05746065
• Evaluate and Optimize an Online Care Model for PrEP Delivery: Pilot StudyCompletedNCT05377138Not applicable
• PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in KenyaCompletedNCT04666792Phase 4
• The Deliver Health StudyCompletedNCT04027153Not applicable
• Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional IncentivesCompletedNCT03808194Not applicable
• Impact of Physical Activity and Diet on Symptom Experience in People Living With HIVStatus unknownNCT03790501
• Partners PrEP ProgramCompletedNCT03586128
• The Prevention Options for Women Evaluation Research (POWER) CohortCompletedNCT03490058
• Point-of-care Viral Load Testing to Enable Streamlined Care and Task Shifting for Chronic HIV CareCompletedNCT03066128Not applicable
• Partners Demonstration Project of PrEP and ARTCompletedNCT02775929Phase 4
• Overcoming Barriers to HIV/AIDS Care and ART InitiationCompletedNCT02718456Not applicable
• Motivation Matters StudyCompletedNCT02627365Not applicable
• Text Messaging to Improve HIV Testing Among Young Women in KenyaCompletedNCT02527135Not applicable
• Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIVCompletedNCT01433185Not applicable
• Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
• Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male CircumcisionCompletedNCT01186575Not applicable
• An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative PersonsWithdrawnNCT01059084Not applicable
• Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in KenyaCompletedNCT00914225
• Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1TerminatedNCT00781287Phase 4
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
• Computer Assisted Rx Education for HIV-Positives: CARE+CompletedNCT00443378Not applicable
• HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
• Highly Active Antiretroviral Therapy (HAART) Adherence InterventionsCompletedNCT00273780Not applicable
• Longitudinal Study of HAART, Social Networks, & AdherenceCompletedNCT00272220Not applicable
• Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan ChildrenCompletedNCT00194545Phase 2
• Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3